Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-113434
Filing Date
2023-11-01
Accepted
2023-11-01 17:00:42
Documents
1
Period of Report
2023-11-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2325388-3_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2325388-3_3seq1.xml 3 3144
  Complete submission text file 0001104659-23-113434.txt   4659
Mailing Address 500 FORBES BLVD SOUTH SAN FRANCISCO CA 94070
Business Address
Hege Kristen (Reporting) CIK: 0001299171 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37368 | Film No.: 231369054

Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)